Description
P53 Phase III clinical trials with amustaline/glutathione (S-303/GSH) pathogen-inactivated RBC
Article: P53 Phase III clinical trials with amustaline/glutathione (S-303/GSH) pathogen-inactivated RBC
€3.03
Related products
-
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart
